IN THE NEWS
-
OPERATING EXPENSES DOWN 20% AND CASH POSITION AT €1.7 M AT JUNE 30, 2025
1st half 2025 results EVRY, FRANCE, THURSDAY, OCTOBER 29, 2025, 5:45 PM - IntegraGen (FR0010908723 - ALINT - PEA PME eligible), a company specializing in cancer genomics,... Read More
-
IntegraGen announces the appointment of Bérengère Génin as Chief Executive Officer
Évry, France, October 21, 2025 - IntegraGen (FR0010908723 - ALINT - PEA PME eligible), a company specializing in the genomics of cancer and rare genetic diseases, which... Read More
-
FIRST-HALF 2023 SALES OF €5.6 M, DOWN 13 % ON S1 2022, AND CASH POSITION OF €4.3 M
EVRY, FRANCE, THURSDAY JULY 13, 2023, 7:30 AM - IntegraGen (FR0010908723 - ALINT - PEA PME eligible), an OncoDNA company specializing in cancer genomics and... Read More
LATEST NEWS
-
OPERATING EXPENSES DOWN 20% AND CASH POSITION AT €1.7 M AT JUNE 30, 2025
1st half 2025 results EVRY, FRANCE, THURSDAY OCTOBER 29, 2025, 5:45 PM - IntegraGen (FR0010908723... Read More
-
IntegraGen announces the appointment of Bérengère Génin as Chief Executive Officer
Évry, France, October 21, 2025 - IntegraGen (FR0010908723 - ALINT - PEA PME eligible), a... Read More
-
FIRST-HALF 2023 SALES OF €5.6 M, DOWN 13 % ON S1 2022, AND CASH POSITION OF €4.3 M
EVRY, FRANCE, THURSDAY JULY 13TH 2023, 7:30 AM - IntegraGen (FR0010908723 - ALINT - PEA eligible... Read More
-
FIRST-HALF 2023 RESULTS - SALES DOWN 13% AND RESILIENT PROFITABILITY
Evry, France, Thursday October 19, 2023, 5:45 pm - IntegraGen (FR0010908723 - ALINT - PEA PME eligible), a... Read More
